Antibody Drug Conjugates - A Groundbreaking Solution to Cancer
The market for antibody drug conjugates is witnessing a fast growth, which is supported by the advancement in medical technology, the rise in the occurrence of cancer cases worldwide, growing ageing population, and the growing obese population. Furthermore, the increased research activities on antibody therapies, advanced drug discoveries and oncology diseases as well as the growing collaboration between research institutes are propelling the growth of the industry. Nonetheless, the high cost of the procedures and the lack of fund pose a threat to the growth of the ADC market. According to a report published by Allied Market Research, the antibody drug conjugates market is expected to reach $3,198 million by 2023, registering a CAGR of 12.9% from 2017 to 2023.
Request sample PDF brochure at: https://www.alliedmarketresearch.com/request-sample/1467
Do purchase inquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/1467